PREDICTED: Homo sapiens RUNX1 partner transcriptional co-repressor 1 ( - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions. [Acta Neuropathol Commun. 2024]
CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A, Lew-Derivry L, Abbou S, Métais A, Pierron G, Reynaud S, Masliah-Planchon J, Mariet C, Hasty L, Dangouloff-Ros V, et al. Acta Neuropathol Commun. 2024 Jan 19; 12(1):12. Epub 2024 Jan 19.
Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1. [Int Immunopharmacol. 2023]
Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1.
Li XP, Dai Y, Zhang WN, Pan MM, Mao J, Zhao B, Jiang L, Gao Y. Int Immunopharmacol. 2023 Dec; 125(Pt B):111178. Epub 2023 Nov 9.
RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1. [Med Oncol. 2023]
RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1.
Azlan A, Khor KZ, Rajasegaran Y, Rosli AA, Said MSM, Yusoff NM, Moses EJ. Med Oncol. 2023 Jun 21; 40(7):208. Epub 2023 Jun 21.